Etoposide is contraindicated in: Patients who have demonstrated a previous hypersensitivity to the preparation; Patients who show evidence of severe hepatic dysfunction.
Etoposide must not be administered by intra-cavitary injection.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.